Tag: CardioCel®
Admedus sells its CardioCel and VascuCel patch business for $A36.2m
ASX-listed health technologies manufacturer Admedus has reached an agreement to sell its CardioCel and VascuCel patch business to US based LeMaitre Vascular Inc. for up to...
Admedus completes acquisition of WA manufacturing site for CardioCel
Admedus has announced that it has completed the purchase of an established manufacturing site from Genzyme Australia to facilitate increased production of its lead...
Featured Article
Don’t get left behind: Manufacturing’s urgent need for digital transformation
As digital transformation reshapes industries worldwide, manufacturers in Australia and beyond are finding themselves at the forefront of an evolution. This shift presents opportunities for companies looking to improve efficiency, drive innovation, and boost growth.
